|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|---|
| Operating activities | |||
| Net income before equity in net income of subsidiaries | |||
| Adjustments to reconcile net income/(loss) after tax to net cash provided by/(used in) operating activities: | |||
| Share compensation expense | |||
| Depreciation | |||
| Accretion, amortization and depreciation | |||
| Net realized (gain)/loss on investments | |||
| Net realized and unrealized (gain)/loss on investments | |||
| Deferred tax expense/(benefit) | |||
| Net changes in assets and liabilities: | |||
| Accrued investment income | |||
| Premiums and other receivables | |||
| Amounts due from The Fidelis Partnership | |||
| Deferred reinsurance premiums | |||
| Reinsurance balances recoverable on paid losses | |||
| Reinsurance balances recoverable on reserves for losses and loss adjustment expenses | |||
| Deferred policy acquisition costs | |||
| Other assets | |||
| Reserves for losses and loss adjustment expenses | |||
| Unearned premiums | |||
| Reinsurance balances payable | |||
| Amounts due to The Fidelis Partnership | |||
| Other liabilities | |||
| Net cash provided by/(used in) operating activities | |||
| Investing activities | |||
| Purchase of available-for-sale securities | |||
| Proceeds from sales and maturities of available-for-sale securities | |||
| Proceeds from maturities of available-for-sale securities | |||
| Proceeds from sales of available-for-sale securities | |||
| Purchase of other investments | |||
| Proceeds from sale of other investments | |||
| Proceeds from the sale of investments, trading | |||
| Purchase of fixed assets | |||
| Net cash provided by/(used in) investing activities | |||
| Financing activities | |||
| Dividends on common shares | |||
| Repurchase of common shares | |||
| Tax paid on withholding shares | |||
| Proceeds from issuance of debt, net of issuance costs | |||
| Repurchase of preferred securities | |||
| Proceeds from issuance of common shares, net of issuance costs | |||
| Non-controlling interest share transactions | |||
| Net cash used in disposal of subsidiary | |||
| Cumulative dividends on warrants | |||
| Net cash provided by/(used in) financing activities | |||
| Effect of exchange rate changes on foreign currency cash | |||
| Net increase/(decrease) in cash, restricted cash, and cash equivalents | |||
| Cash, restricted cash, and cash equivalents, beginning of year | |||
| Cash, restricted cash, and cash equivalents, end of year | |||
| Supplemental disclosure of cash flow information: | |||
| Net cash paid during the year for income taxes | |||
| Cash paid during the year for interest |
Loading...